BFGF enhances the IGFs-mediated pluripotent and differentiation potentials in multipotent stem cells

Growth Factors

Volumn 27, Issue 6, 2009, Pages 425-437

  Park, Sang Bum ^a   Yu, Kyung Rok ^a   Jung, Ji Won ^a   Lee, Sae Rom ^a   Roh, Kyoung Hwan ^a   Seo, Min Soo ^a   Park, Jeong Ran ^a   Kang, Soo Kyung ^a   Lee, Yong Soon ^a   Kang, Kyung Sun ^a  

^a Seoul National University   (South Korea)

Author keywords

BFGF; FGFR1; IGF; IGF1R; Multipotent stem cells; Umbilical cord blood

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIPOTENT STEM CELL; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FETAL BLOOD; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MULTIPOTENT STEM CELLS; PLURIPOTENT STEM CELLS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

EID: 70450192531     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903289875     Document Type: Article

References (39)

1. Akita S, FukuiM,NakagawaH, FujiiT, Akino K. 2004. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen 12: 252-259.
2. Anzai H, Nagayoshi M, Obata M, Ikawa Y, Atsumi T. 1999. Self-renewal and differentiation of a basic fibroblast growth factor-dependent multipotent hematopoietic cell line derived from embryonic stem cells. Dev Growth Differ 41: 51-58.
3. Barry FP, Murphy JM. 2004. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
4. Basilico C, Moscatelli D. 1992. The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165.
5. Benavente CA, Sierralta WD, Conget PA, Minguell JJ. 2003. Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth Factors 21:87-94.
6. Bendall SC, StewartMH, Menendez P, GeorgeD, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, Bosse M, Lajoie G, Bhatia M. 2007. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448:1015-1021.
7. Boney CM, Smith RM,Gruppuso PA. 1998. Modulation of insulinlike growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation. Endocrinology 139:1638-1644.
8. Burgering BM, Coffer PJ. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602.
9. Gabbitas B, Pash J, Canalis E. 1994. Regulation of insulin-like growth factor-II synthesis in bone cell cultures by skeletal growth factors. Endocrinology 135:284-289.
10. Gabrilove JL, White K, Rahman Z, Wilson EL. 1994. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting committed myeloid progenitor cell growth. Blood 83:907-910.
11. Hanada K, Dennis JE, Caplan AI. 1997. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12:1606-1614.
12. Hernandez-Sanchez C, Werner H, Roberts CT, Jr., Woo EJ, Hum DW, Rosenthal SM, LeRoith D. 1997. Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor. J Biol Chem 272: 4663-4670.
13. Hofmann F, Garcia-Echeverria C. 2005. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today 10:1041-1047.
14. Hwang JW, Park JS, Jo EH, Kim SJ, Yoon BS, Kim SH, Lee YS, Kang KS. 2005. Chinese cabbage extracts and sulforaphane can protect H2O2-induced inhibition of gap junctional intercellular communication through the inactivation of ERK1/2 and p38 MAP kinases. J Agric Food Chem 53:8205-8210.
15. Koch H, Jadlowiec JA, Campbell PG. 2005. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev 14:621-631.
16. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675.
17. Levenstein ME, Ludwig TE, Xu RH, Llanas RA, VanDenHeuvel-Kramer K, Manning D, Thomson JA. 2006. Basic fibroblast growth factor support of human embryonic stem cell selfrenewal. Stem Cells 24:568-574.
18. Li Y, Yu X, Lin S, Li X, Zhang S, Song YH. 2007. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356:780-784.
19. Maric D, Maric I, Chang YH, Barker JL. 2003. Prospective cell sorting of embryonic rat neural stem cells and neuronal and glial progenitors reveals selective effects of basic fibroblast growth factor and epidermal growth factor on self-renewal and differentiation. J Neurosci 23:240-251.
20. Minamide A, Yoshida M, Kawakami M, Okada M, Enyo Y, Hashizume H, Boden SD. 2007. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine 32:1067-1071.
21. Mohammadi M, McMahon G, Sun L, Tang C, Hirth P, Yeh BK, Hubbard SR, Schlessinger J. 1997. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276:955-960.
22. Neubauer M, Fischbach C, Bauer-Kreisel P, Lieb E, Hacker M, Tessmar J, Schulz MB, Goepferich A, Blunk T. 2004. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett 577: 277-283.
23. Neubauer M, Hacker M, Bauer-Kreisel P, Weiser B, Fischbach C, Schulz MB, Goepferich A, Blunk T. 2005. Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng 11:1840-1851.
24. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D. 1997. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138:1427-1433.
25. Peng H, Myers J, Fang X, Stachowiak EK, Maher PA,Martins GG, Popescu G, Berezney R, Stachowiak MK. 2002. Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. J Neurochem 81:506-524.
26. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
27. Pons S, Torres-Aleman I. 1992. Basic fibroblast growth factor modulates insulin-like growth factor-I, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology 131:2271-2278.
28. Russo VC, Gluckman PD, Feldman EL, Werther GA. 2005. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 26:916-943.
29. Sakimura K, Matsumoto T, Miyamoto C, Osaki M, Shindo H. 2006. Effects of insulin-like growth factor I on transforming growth factor beta1 induced chondrogenesis of synoviumderived mesenchymal stem cells cultured in a polyglycolic acid scaffold. Cells Tissues Organs 183:55-61.
30. Scavo LM, Karas M, Murray M, Leroith D. 2004. Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes. J Clin Endocrinol Metab 89:3543-3553.
31. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W. 2006. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750-1758.
32. Shen FH, Visger JM, Balian G, Hurwitz SR, Diduch DR. 2002. Systemically administered mesenchymal stromal cells transduced with insulin-like growth factor-I localize to a fracture site and potentiate healing. J Orthop Trauma 16:651-659.
33. Stewart AA, Byron CR, Pondenis H, Stewart MC. 2007. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res 68: 941-945.
34. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
35. Varas L, Ohlsson LB, Honeth G, Olsson A, Bengtsson T, Wiberg C, Bockermann R, Jarnum S, Richter J, Pennington D, Johnstone B, Lundgren-Akerlund E, Kjellman C. 2007. Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential. Stem Cells Dev 16:965-978.
36. Xiong L, Kou F, Yang Y, Wu J. 2007. A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop. J Cell Biol 178:995-1007.
37. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. 2005. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2:185-190.
38. Yang SR, Cho SD, Ahn NS, Jung JW, Park JS, Jo EH, Hwang JW, Kim SH, Lee BH, Kang KS, Lee YS. 2005. The role of p38 MAP kinase and c-Jun N-terminal protein kinase signaling in the differentiation and apoptosis of immortalized neural stem cells. Mutat Res 579:47-57.
39. Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z, Wang LH. 2006. RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage- independent growth. Mol Cell Biol 26:413-424.